Nirvana Life Sciences Inc.
Nirvana Life Sciences Inc.
Indice CSE:
Devise:
Nirvana Life Sciences Inc. is focused on developing medical products and regimens that address addiction. Nirvana is working on novel formulations of psilocybin and other naturally-sourced psychedelics to treat pain, opioid dependency and other health problems.
Nirvana Life Sciences Inc. (NIRV)
SEDAR Information
Information d'entreprise
Addresse
Suite 2110, 650 West Georgia Street
Vancouver, BC V6B 4N8
CanadaTéléphone
(604) 401-8100Courriel
Info@nirvanalifescience.comURL
https://nirvanalifescience.comDate d’inscription à la cote
Jeudi, mars 17, 2022
Agent de transfert
Computershare Investor Services Inc.Capitalisation
Capitalisation:
33,020,139Réservé à l'émission:
300,000Communiqués de presse
09/06/2022
Nirvana reports Patent Filing
Bulletins
Advertisement
Publicité
Évènements à venir
